Mamografía como instrumento de tami zaje en cáncer de mama

Julio Abugattas Saba; Javier Manrique Hinojosa; Tatiana Vidaurre Rojas

doi:10.31403/rpgo.v61i1862

Authors

Julio Abugattas Saba Sub-Jefe Institucional del OPE, Médico Asistente del Departamento de Mamas, Tejidos Blandos y Piel, Instituto Nacional de Enfermedades Neoplásicas (INEN) “Dr. Eduardo Cáceres Graziani”
Javier Manrique Hinojosa Director Ejecutivo del Departamento de Promoción de la Salud, Prevención y Control Nacional del Cáncer, Jefe del Departamento de Prevención y Diagnóstico, Instituto Nacional de Enfermedades Neoplásicas (INEN) “Dr. Eduardo Cáceres Graziani”
Tatiana Vidaurre Rojas Jefe Institucional del OPE, Médico Asistente del Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas (INEN) “Dr. Eduardo Cáceres Graziani”

DOI:

https://doi.org/10.31403/rpgo.v61i1862

Abstract

Breast cancer is the second most frequent malignant neoplasm in the world and the fifth cause of death from cancer in women. In Peru, breast cancer is second in incidence and the third cause of death from cancer in women. Mammography screening began in 1960 with the goal of detecting cancer at its smallest size before clinically evident in order to have better prognosis and survival. Several trials have been done since to determine mammography importance as a screening method and to establish age to begin, frequency and when to stop screening. In this article the role of mammography as screening tool is reviewed, as well as controversies on use, side effects, and recommendations on its use in Peru.